vs
APOGEE ENTERPRISES, INC.（APOG）与Ascendis Pharma A/S（ASND）财务数据对比。点击上方公司名可切换其他公司
APOGEE ENTERPRISES, INC.的季度营收约是Ascendis Pharma A/S的1.3倍（$351.4M vs $267.3M），Ascendis Pharma A/S同比增速更快（42.3% vs 1.6%），过去两年Ascendis Pharma A/S的营收复合增速更高（60.7% vs 2.9%）
Apogee Enterprises是一家美国音频设备制造商，主营音频接口、模数与数模转换器、USB及iOS麦克风，同时还开发音频制作相关软件，产品广泛服务于专业录音、音乐创作等音频领域，在全球音频行业拥有较高的认可度。
Ascendis Pharma A/S是一家聚焦内分泌疾病治疗领域的生物制药企业，核心业务覆盖生长激素疗法的研发、生产与商业化。其依托重组DNA技术生产的生长激素类处方药物，可用于治疗多种生长激素缺乏相关适应症，临床应用场景广泛。
APOG vs ASND — 直观对比
营收规模更大
APOG
是对方的1.3倍
$267.3M
营收增速更快
ASND
高出40.7%
1.6%
两年增速更快
ASND
近两年复合增速
2.9%
损益表 — Q4 FY2026 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $351.4M | $267.3M |
| 净利润 | $16.6M | — |
| 毛利率 | 22.4% | 90.5% |
| 营业利润率 | 7.3% | — |
| 净利率 | 4.7% | — |
| 营收同比 | 1.6% | 42.3% |
| 净利润同比 | 568.8% | — |
| 每股收益（稀释后） | $0.78 | — |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收APOGASND
| Q1 26 | $351.4M | — | ||
| Q4 25 | $348.6M | $267.3M | ||
| Q3 25 | $358.2M | $230.7M | ||
| Q2 25 | $346.6M | $170.7M | ||
| Q1 25 | $345.7M | $109.0M | ||
| Q4 24 | $341.3M | $187.8M | ||
| Q3 24 | $342.4M | $62.5M | ||
| Q2 24 | $331.5M | $38.9M |
净利润APOGASND
| Q1 26 | $16.6M | — | ||
| Q4 25 | $16.5M | — | ||
| Q3 25 | $23.6M | $-65.9M | ||
| Q2 25 | $-2.7M | $-42.0M | ||
| Q1 25 | $2.5M | $-102.2M | ||
| Q4 24 | $21.0M | — | ||
| Q3 24 | $30.6M | $-107.1M | ||
| Q2 24 | $31.0M | $-118.1M |
毛利率APOGASND
| Q1 26 | 22.4% | — | ||
| Q4 25 | 23.8% | 90.5% | ||
| Q3 25 | 23.1% | 89.5% | ||
| Q2 25 | 21.7% | 80.1% | ||
| Q1 25 | 21.6% | 82.6% | ||
| Q4 24 | 26.1% | 91.9% | ||
| Q3 24 | 28.4% | 80.6% | ||
| Q2 24 | 29.8% | 68.2% |
营业利润率APOGASND
| Q1 26 | 7.3% | — | ||
| Q4 25 | 7.1% | — | ||
| Q3 25 | 7.5% | 5.1% | ||
| Q2 25 | 2.0% | -33.5% | ||
| Q1 25 | 1.8% | -103.2% | ||
| Q4 24 | 8.4% | — | ||
| Q3 24 | 12.3% | -167.3% | ||
| Q2 24 | 12.5% | -370.2% |
净利率APOGASND
| Q1 26 | 4.7% | — | ||
| Q4 25 | 4.7% | — | ||
| Q3 25 | 6.6% | -28.5% | ||
| Q2 25 | -0.8% | -24.6% | ||
| Q1 25 | 0.7% | -93.7% | ||
| Q4 24 | 6.1% | — | ||
| Q3 24 | 8.9% | -171.5% | ||
| Q2 24 | 9.4% | -303.9% |
每股收益（稀释后）APOGASND
| Q1 26 | $0.78 | — | ||
| Q4 25 | $0.77 | — | ||
| Q3 25 | $1.10 | — | ||
| Q2 25 | $-0.13 | — | ||
| Q1 25 | $0.12 | — | ||
| Q4 24 | $0.96 | — | ||
| Q3 24 | $1.40 | — | ||
| Q2 24 | $1.41 | — |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $39.5M | $665.3M |
| 总债务越低越好 | $232.3M | — |
| 股东权益账面价值 | $511.8M | $-175.8M |
| 总资产 | $1.1B | $1.4B |
| 负债/权益比越低杠杆越低 | 0.45× | — |
8季度趋势，按日历期对齐
现金及短期投资APOGASND
| Q1 26 | $39.5M | — | ||
| Q4 25 | $41.3M | $665.3M | ||
| Q3 25 | $39.5M | $582.2M | ||
| Q2 25 | $32.8M | $533.6M | ||
| Q1 25 | $41.4M | $559.4M | ||
| Q4 24 | $43.9M | $604.3M | ||
| Q3 24 | $51.0M | $675.6M | ||
| Q2 24 | $30.4M | $279.4M |
总债务APOGASND
| Q1 26 | $232.3M | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | $285.0M | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
股东权益APOGASND
| Q1 26 | $511.8M | — | ||
| Q4 25 | $512.3M | $-175.8M | ||
| Q3 25 | $500.2M | $-188.0M | ||
| Q2 25 | $481.8M | $-202.6M | ||
| Q1 25 | $487.9M | $-205.0M | ||
| Q4 24 | $522.1M | $-114.2M | ||
| Q3 24 | $506.4M | $-105.1M | ||
| Q2 24 | $480.0M | $-346.8M |
总资产APOGASND
| Q1 26 | $1.1B | — | ||
| Q4 25 | $1.1B | $1.4B | ||
| Q3 25 | $1.2B | $1.2B | ||
| Q2 25 | $1.2B | $1.2B | ||
| Q1 25 | $1.2B | $1.1B | ||
| Q4 24 | $1.2B | $1.3B | ||
| Q3 24 | $917.1M | $1.2B | ||
| Q2 24 | $889.0M | $819.0M |
负债/权益比APOGASND
| Q1 26 | 0.45× | — | ||
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 0.58× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $122.5M | $58.2M |
| 自由现金流经营现金流 - 资本支出 | — | — |
| 自由现金流率自由现金流/营收 | — | — |
| 资本支出强度资本支出/营收 | 7.8% | — |
| 现金转化率经营现金流/净利润 | 7.37× | — |
| 过去12个月自由现金流最近4个季度 | — | — |
8季度趋势，按日历期对齐
经营现金流APOGASND
| Q1 26 | $122.5M | — | ||
| Q4 25 | $29.3M | $58.2M | ||
| Q3 25 | $57.1M | — | ||
| Q2 25 | $-19.8M | — | ||
| Q1 25 | $30.0M | $-15.5M | ||
| Q4 24 | $31.0M | $-330.7M | ||
| Q3 24 | $58.7M | — | ||
| Q2 24 | $5.5M | — |
自由现金流APOGASND
| Q1 26 | — | — | ||
| Q4 25 | $22.9M | — | ||
| Q3 25 | $52.4M | — | ||
| Q2 25 | $-26.9M | — | ||
| Q1 25 | $19.1M | — | ||
| Q4 24 | $22.0M | — | ||
| Q3 24 | $50.2M | — | ||
| Q2 24 | $-1.8M | — |
自由现金流率APOGASND
| Q1 26 | — | — | ||
| Q4 25 | 6.6% | — | ||
| Q3 25 | 14.6% | — | ||
| Q2 25 | -7.8% | — | ||
| Q1 25 | 5.5% | — | ||
| Q4 24 | 6.4% | — | ||
| Q3 24 | 14.7% | — | ||
| Q2 24 | -0.5% | — |
资本支出强度APOGASND
| Q1 26 | 7.8% | — | ||
| Q4 25 | 1.9% | — | ||
| Q3 25 | 1.3% | — | ||
| Q2 25 | 2.1% | — | ||
| Q1 25 | 3.2% | — | ||
| Q4 24 | 2.6% | — | ||
| Q3 24 | 2.5% | — | ||
| Q2 24 | 2.2% | — |
现金转化率APOGASND
| Q1 26 | 7.37× | — | ||
| Q4 25 | 1.77× | — | ||
| Q3 25 | 2.41× | — | ||
| Q2 25 | — | — | ||
| Q1 25 | 12.08× | — | ||
| Q4 24 | 1.48× | — | ||
| Q3 24 | 1.92× | — | ||
| Q2 24 | 0.18× | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
APOG
| Architectural Services | $127.1M | 36% |
| Architectural Metals | $110.0M | 31% |
| Architectural Glass | $67.4M | 19% |
| Performance Surfaces | $54.3M | 15% |
ASND
暂无分部数据
